301 related articles for article (PubMed ID: 29297754)
1. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population-based informatics prompted reminder on screening rates.
MacLaughlin KL; Swanson KM; Naessens JM; Angstman KB; Chaudhry R
J Eval Clin Pract; 2014 Apr; 20(2):136-43. PubMed ID: 24237657
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of two outreach strategies for cervical cancer screening.
Bowles EJ; Gao H; Brandzel S; Bradford SC; Buist DS
Prev Med; 2016 May; 86():19-27. PubMed ID: 26820221
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
[TBL] [Abstract][Full Text] [Related]
5. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
6. Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.
Momany MC; Martinez-Gutierrez J; Soto M; Capurro D; Ciampi F; Thompson B; Puschel K
BMC Cancer; 2017 Dec; 17(1):847. PubMed ID: 29237420
[TBL] [Abstract][Full Text] [Related]
7. Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study.
Mignot S; Ringa V; Vigoureux S; Zins M; Panjo H; Saulnier PJ; Fritel X
BMC Cancer; 2019 Apr; 19(1):317. PubMed ID: 30952209
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
Buehler SK; Parsons WL
CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
[TBL] [Abstract][Full Text] [Related]
9. Timely reminder interventions to improve annual Papanicolaou (Pap) smear rates among HIV-infected women in an outpatient center of southern Nevada: a short report.
Ganta V; Moonie S; Patel D; Hunt AT; Richardson J; Di John D; Ezeanolue EE
AIDS Care; 2017 Sep; 29(9):1099-1101. PubMed ID: 28460538
[TBL] [Abstract][Full Text] [Related]
10. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
12. Clinical decision support with automated text processing for cervical cancer screening.
Wagholikar KB; MacLaughlin KL; Henry MR; Greenes RA; Hankey RA; Liu H; Chaudhry R
J Am Med Inform Assoc; 2012; 19(5):833-9. PubMed ID: 22542812
[TBL] [Abstract][Full Text] [Related]
13. Cervical testing beyond the screening target age - A register-based cohort study from Finland.
Keltto N; Leivonen A; Pankakoski M; Sarkeala T; Heinävaara S; Anttila A
Gynecol Oncol; 2021 Aug; 162(2):315-321. PubMed ID: 34074539
[TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Screening Among Homeless Women of New York City Shelters.
Asgary R; Alcabes A; Feldman R; Garland V; Naderi R; Ogedegbe G; Sckell B
Matern Child Health J; 2016 Jun; 20(6):1143-50. PubMed ID: 26649876
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
16. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
[TBL] [Abstract][Full Text] [Related]
17. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
18. A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
Atlas SJ; Tosteson ANA; Wright A; Orav EJ; Burdick TE; Zhao W; Hort SJ; Wint AJ; Smith RE; Chang FY; Aman DG; Thillaiyapillai M; Diamond CJ; Zhou L; Haas JS
JAMA; 2023 Oct; 330(14):1348-1358. PubMed ID: 37815566
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening and Pap test non-adherence risk factors in systemic sclerosis patients.
Kavosi H; Javinani A; Kazemi-Rahmatabadi Z; Alyasin A; Sefidbakht S; Gharibdoost F; Jamshidi AR; Mirbeyk M; Imeni V; Gorgani F; Tamartash Z
Eur J Cancer Prev; 2020 May; 29(3):266-269. PubMed ID: 31567538
[TBL] [Abstract][Full Text] [Related]
20. Limitations in Correspondence Programs for Cervical Cancer Screening: Who Are the Women We Are Missing?
Clark M; Lee A; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1410-1415. PubMed ID: 30803876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
